Critically important antimicrobials for human medicine, 6th revision; 2017

The WHO Advisory Group on Integrated Surveillance of Antimicrobial Resistance (AGISAR) reviews and updates the WHO list of critically important antimicrobials for human medicine every two years. This document provides a ranking of medically important antimicrobials for risk management of antimicrobial resistance due to non-human use. The current revision was undertaken by the eighth meeting of the AGISAR held in Utrecht, the Netherlands in 2018.